Posts by: Patricia Inacio, PhD

News

The U.S. Department of Defense (DoD) has awarded Mayo Clinic researchers $11 million to conduct a Phase 2 trial investigating the TPIV110 vaccine, in combination with Herceptin (trastuzumab), as a ... Read more

November 7, 2018

Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers

News

An upcoming Phase 2 trial will evaluate a combination of the immunotherapies Keytruda (pembrolizumab) and tomivosertib (eFT508) as a treatment for triple-negative breast cancer patients whose disease has spread to ... Read more

October 15, 2018

First Patient Dosed in Phase 1/2 Trial of FLX475 in Breast, Other Advanced Cancers

News

The first patient has been dosed in a Phase 1/2 trial evaluating FLX Bio’s investigational therapy, FLX475, alone and in combination with the PD-1 inhibitor Keytruda (pembrolizumab), as a therapy for ... Read more

September 24, 2018

First Patient Dosed in Phase 1b Trial Testing Cirmtuzumab Add-on in HER2-negative Breast Cancer Patients

News

A pilot Phase 1 trial evaluating Oncternal Therapeutic’s investigational therapy cirmtuzumab as an add-on to standard chemotherapy for patients with advanced, HER2-negative breast cancer who cannot receive surgery has started ... Read more

September 17, 2018

Online Test Measures Women’s Risk of Cancer Recurrence or Spread After Hormone Therapy

News

A newly developed online prognostic tool can determine whether a woman is at high risk of cancer recurrence or spread after receiving the standard five years of hormone therapy, ... Read more

August 23, 2018August 23, 2018

Genome Analysis of DNA from Nigerian Women Leads to 1st African Breast Cancer Risk Prediction Model

News

A genome analysis of the DNA of Nigerian women uncovered a higher burden of mutations in breast cancer-related genes, which may explain why sub-Saharan African women are more likely ... Read more

June 11, 2018

Number of Circulating Tumor Cells in Blood May Allow for Less Aggressive Treatment of Advanced Cancers

News

Using blood samples to count circulating tumor cells may help to classify metastatic breast cancer patients according to their tumors’ aggressiveness, raising the possibility of more tailored treatments, with ... Read more

May 31, 2018

Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial

News

BriaCell Therapeutics‘ immunotherapy candidate Bria-IMT was found to be safe and well-tolerated, and significantly reduced the size of metastasis in two of the six breast cancer patients treated in a Phase ... Read more

May 30, 2018

Regardless of Age, Surgery Best for Most Early-stage Breast Cancers, Study Says

News

Women 70 or older who were diagnosed with estrogen receptor-positive breast cancer had higher mortality rates when treated with endocrine therapies compared to surgery, a recent U.K. study shows. ... Read more

May 18, 2018

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds

News

Physical exercise may help breast cancer survivors overcome many of the side effects associated with cancer therapy, but studies show that up to 70% of patients don’t exercise enough. ... Read more

Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

DoD Awards $11M for Phase 2 Trial of TPIV110 Breast Cancer Therapy

Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers

First Patient Dosed in Phase 1/2 Trial of FLX475 in Breast, Other Advanced Cancers

First Patient Dosed in Phase 1b Trial Testing Cirmtuzumab Add-on in HER2-negative Breast Cancer Patients

Online Test Measures Women’s Risk of Cancer Recurrence or Spread After Hormone Therapy

Genome Analysis of DNA from Nigerian Women Leads to 1st African Breast Cancer Risk Prediction Model

Number of Circulating Tumor Cells in Blood May Allow for Less Aggressive Treatment of Advanced Cancers

Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial

Regardless of Age, Surgery Best for Most Early-stage Breast Cancers, Study Says

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds

Pin It on Pinterest